FDA says nipple cream could harm infants
WASHINGTON (Reuters) - Consumers should not buy or use Mommy's Bliss Nipple Cream, marketed by San Rafael, California-based MOM Enterprises Inc, due to ingredients that could harm infants, the U.S. Food and Drug Administration said on Friday.
The product, marketed to nursing mothers to help soothe and heal their dry or cracked nipples, contains ingredients chlorphenesin and phenoxyethanol that could cause respiratory distress or vomiting and diarrhea in infants, the FDA said.
The agency said the company has stated it has discontinued marketing the product. It also said it has not received any reports of injury to infants.
"FDA is particularly concerned that nursing infants are being unwittingly exposed by their mothers to this product with dangerous side effects," Dr. Janet Woodcock, director of the FDA's Center for Drug Evaluation and Research, said in a statement.
"Additionally, these two ingredients may interact with one another to further compound and increase the risk of respiratory depression in nursing infants," Woodcock said.
(Reporting by Will Dunham; editing by Mohammad Zargham)
© Thomson Reuters 2009 All rights reserved
One Year Later
Mumbai held tearful memorials and police staged a show of strength as it marked the first anniversary of militant raids that killed 166 people and pushed up tensions with Pakistan. Slideshow | Full Coverage
Liberhan Commission Report
The government published a long awaited report, recently leaked, accusing BJP leaders of a role in the 1992 destruction of the Babri mosque in Ayodhya. Full Article
